Skip to main content
. 2022 Oct 6;19(3):117–121. doi: 10.5114/kitp.2022.119758

Table III.

Histopathological evaluation of the nodules

Group 1 (n = 54) Group 2 (n = 37)
Adenocarcinoma 35 Colon 12
Breast 7
Squamous cell carcinoma 15 Sarcomas 9
Thyroid 1
Large cell carcinoma 2 Hepatocellular 1
Malignant melanoma 2
Renal cell carcinoma 1
Neuroendocrine tumor 2 Gastric cancer 2
Pancreatobiliary cancers